Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity

被引:26
作者
Bochkis, Irina Mikhailovna
Shin, Soona
Kaestner, Klaus Hermann [1 ]
机构
[1] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
关键词
Bile acids; Aging; Winged helix transcription factors; mTOR pathway; Hepatic lip genesis; Foxa proteins; NF-KAPPA-B; GROWTH-HORMONE; X-RECEPTOR; TRANSCRIPTIONAL RESPONSE; MAMMALIAN TARGET; BODY GROWTH; PATHWAY; HEPATOCYTE; GLUCOSE; STAT5B;
D O I
10.1016/j.molmet.2013.08.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Cytokine signaling has been connected to regulation of metabolism and energy balance. Numerous cytokine gene expression changes are stimulated by accumulation of bile acids in livers of young Foxa2 liver-conditional null mice. We hypothesized that bile acid-induced inflammation in young Foxa2 mutants, once chronic, affects metabolic homeostasis. We found that loss of Foxa2 in the liver results in a premature aging phenotype, including significant weight gain, reduced food intake, and decreased energy expenditure. We show that Foxa2 antagonizes the mammalian target of rapamycin (mTOR) pathway, resulting in increased hepatic lipogenesis and adiposity. While much prior work has focused on adipose tissue in obesity, we discovered a novel age-onset obesity phenotype in a model where gene deletion occurs only in the liver, underscoring the importance of the role hepatic lipogenesis plays in the development of obesity. (C) 2013 The Authors. Published by Elsevier GmbH. All rights reserved.
引用
收藏
页码:447 / 456
页数:10
相关论文
共 64 条
[1]
Bile Acids Induce Inflammatory Genes in Hepatocytes A Novel Mechanism of Inflammation during Obstructive Cholestasis [J].
Allen, Katryn ;
Jaeschke, Hartmut ;
Copple, Bryan L. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01) :175-186
[2]
Alterations in xenobiotic metabolism in the long-lived Little mice [J].
Amador-Noguez, Daniel ;
Dean, Adam ;
Huang, Wendong ;
Setchell, Kenneth ;
Moore, David ;
Darlington, Gretchen .
AGING CELL, 2007, 6 (04) :453-470
[3]
Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism [J].
Baik, Myunggi ;
Yu, Ji Hoon ;
Hennighausen, Lothar .
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2011, 1229 :29-37
[4]
Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues [J].
Besnard, V ;
Wert, SE ;
Hull, WM ;
Whitsett, JA .
GENE EXPRESSION PATTERNS, 2004, 5 (02) :193-208
[5]
Disruption of the Growth Hormone-Signal Transducer and Activator of Transcription 5-Insulinlike Growth Factor 1 Axis Severely Aggravates Liver Fibrosis in a Mouse Model of Cholestasis [J].
Blaas, Leander ;
Kornfeld, Jan-Wilhelm ;
Schramek, Daniel ;
Musteanu, Monica ;
Zollner, Gernot ;
Gumhold, Judith ;
van Zijl, Franziska ;
Schneller, Doris ;
Esterbauer, Harald ;
Egger, Gerda ;
Mair, Markus ;
Kenner, Lukas ;
Mikulits, Wolfgang ;
Eferl, Robert ;
Moriggl, Richard ;
Penninger, Josef ;
Trauner, Michael ;
Casanova, Emilio .
HEPATOLOGY, 2010, 51 (04) :1319-1326
[6]
Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress [J].
Bochkis, Irina M. ;
Rubins, Nir E. ;
White, Peter ;
Furth, Emma E. ;
Friedman, Joshua R. ;
Kaestner, Klaus H. .
NATURE MEDICINE, 2008, 14 (08) :828-836
[7]
Foxa2-dependent hepatic gene regulatory networks depend on physiological state [J].
Bochkis, Irina M. ;
Schug, Jonathan ;
Rubins, Nir E. ;
Chopra, Atul R. ;
O'Malley, Bert W. ;
Kaestner, Klaus H. .
PHYSIOLOGICAL GENOMICS, 2009, 38 (02) :186-195
[8]
Cabana VG, 1996, J LIPID RES, V37, P2662
[9]
FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor [J].
Chen, Chia-Chen ;
Jeon, Sang-Min ;
Bhaskar, Prashanth T. ;
Nogueira, Veronique ;
Sundararajan, Deepa ;
Tonic, Ivana ;
Park, Youngkyu ;
Hay, Nissim .
DEVELOPMENTAL CELL, 2010, 18 (04) :592-604
[10]
Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice [J].
Chen, Chong ;
Liu, Yu ;
Liu, Yang ;
Zheng, Pan .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11) :4091-4101